Key facts
- Behrenbruch Christian filed SCHEDULE 13G for Telix Pharmaceuticals Ltd Ordinary Shares (TLX).
- Disclosed ownership: 7%.
- Date of event: 12 Nov 2024.
Behrenbruch Christian - 12 Nov 2024 SCHEDULE 13G Report for Telix Pharmaceuticals Ltd Ordinary Shares (TLX)
- Filing Manager
- Behrenbruch Christian
- Reporting Manager
- Behrenbruch Christian
- Symbol
- TLX
- Shares outstanding
- 334,705,968 shares
- Disclosed Ownership
- 23,329,006 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 07:00:11 UTC
- Date of event
- 12 Nov 2024
- SEC
- View on sec.gov
Key filing fact
Behrenbruch Christian disclosed 7% ownership in Telix Pharmaceuticals Ltd Ordinary Shares (TLX) on 12 Nov 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 07:00.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Behrenbruch Christian | 7% | 23,329,006 | 654,006 | 22,675,000 | /s/ Dr. Christian Behrenbruch | Behrenbruch Christian | |
| Elk River Holdings Pty Ltd | 6.8% | 22,675,000 | 0 | 22,675,000 | /s/ Dr. Christian Behrenbruch | Dr. Christian Behrenbruch/Director |
CIK / CUSIP context first